- Home
- AQST vs SNCY Comparison
AQST vs SNCY Comparison
Compare AQST & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | SNCY |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 652.6M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AQST | SNCY |
|---|---|---|
| Price | $5.93 | $13.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $10.00 | ★ $19.17 |
| AVG Volume (30 Days) | ★ 2.9M | 759.2K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.51 |
| EPS | N/A | ★ 1.05 |
| Revenue | $43,397,000.00 | ★ $1,106,213,000.00 |
| Revenue This Year | N/A | $6.16 |
| Revenue Next Year | $51.39 | $9.63 |
| P/E Ratio | ★ N/A | $13.18 |
| Revenue Growth | N/A | ★ 4.27 |
| 52 Week Low | $2.12 | $8.10 |
| 52 Week High | $7.55 | $18.59 |
Technical Indicators
Market Signals| Indicator | AQST | SNCY |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 65.05 |
| Support Level | $5.73 | $13.18 |
| Resistance Level | $6.40 | $13.90 |
| Average True Range (ATR) | 0.35 | 0.65 |
| MACD | 0.05 | 0.18 |
| Stochastic Oscillator | 63.03 | 89.81 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.